Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Velosa

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1986
Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndromeJ A Velosa, V E Torres
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 1999
Hantavirus-specific IgG, IgM, and IgA in acute and chronic renal disease versus congenital renal disease in the United StatesM Patnaik, J A Velosa, J B Peter
Mayo Clinic Proceedings|June 1, 1993
Prospective study of anti-neutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitisJ A Velosa, H A Homburger, K E Holley
Mayo Clinic Proceedings|March 11, 1975
Focal sclerosing glomerulonephropathy: a clinicopathologic studyJ A Velosa, J V Donadio, K E Holley
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1977
Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosisR J Glasser, J A Velosa, A F Michael
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1987
Analysis of risk factors for patient and renal survival in crescentic glomerulonephritisR L Heilman, K P Offord, K E Holley, et al.
Mayo Clinic Proceedings|September 1, 1983
Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosisJ A Velosa, K E Holley, V E Torres, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 5, 2001
Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safetyJ A Velosa, T S Larson, J M Gloor, et al.
Clinical Nephrology|August 1, 1981
IgA-IgG nephropathy: predictive indices of progressive diseaseS A Hood, J A Velosa, K E Holley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1980
A new lymphocyte surface protein present in normal urine. II. Cellular distribution and biologic propertiesJ A Velosa, N J Calvanico, W L Anderson, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1986
Benefits and risks of nonsteroidal antiinflammatory drugs in steroid-resistant nephrotic syndromeJ A Velosa, V E Torres
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 9, 1999
Hantavirus-specific IgG, IgM, and IgA in acute and chronic renal disease versus congenital renal disease in the United StatesM Patnaik, J A Velosa, J B Peter
Mayo Clinic Proceedings|June 1, 1993
Prospective study of anti-neutrophil cytoplasmic autoantibody tests in the diagnosis of idiopathic necrotizing-crescentic glomerulonephritis and renal vasculitisJ A Velosa, H A Homburger, K E Holley
Mayo Clinic Proceedings|March 11, 1975
Focal sclerosing glomerulonephropathy: a clinicopathologic studyJ A Velosa, J V Donadio, K E Holley
Laboratory Investigation; a Journal of Technical Methods and Pathology|May 1, 1977
Experimental model of focal sclerosis. I. Relationship to protein excretion in aminonucleoside nephrosisR J Glasser, J A Velosa, A F Michael
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1987
Analysis of risk factors for patient and renal survival in crescentic glomerulonephritisR L Heilman, K P Offord, K E Holley, et al.
Mayo Clinic Proceedings|September 1, 1983
Significance of proteinuria on the outcome of renal function in patients with focal segmental glomerulosclerosisJ A Velosa, K E Holley, V E Torres, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 5, 2001
Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safetyJ A Velosa, T S Larson, J M Gloor, et al.
Clinical Nephrology|August 1, 1981
IgA-IgG nephropathy: predictive indices of progressive diseaseS A Hood, J A Velosa, K E Holley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1980
A new lymphocyte surface protein present in normal urine. II. Cellular distribution and biologic propertiesJ A Velosa, N J Calvanico, W L Anderson, et al.
Pageof 5